2022 SCAI SHOCK

CSRC Session 2: Mini Think Tank – Making Prospective Shock Studies Less Burdensome

Academic View
Navin K. Kapur, M.D., FSCAI, Tufts Medical Center, Boston, MA
Professional Society View
Timothy D. Henry, M.D., MSCAI, The Christ Hospital Health Network, Covington, KY
Regulatory View
Mauro Moscucci, US Food and Drug Administration, Silver Spring, MD
Industry View
Charles A. Simonton, M.D., ABIOMED, Danvers, MA
Panel Discussion
Alexander G. Truesdell, M.D., FSCAI1, Eric Vang, PhD2, Christine Rutan, BA3, Norman Stockbridge4, Mauro Moscucci5 and Nicole Gillette5, (1)Virginia Heart / Inova Schar Heart and Vascular Institute, Mclean, VA, (2)Medtronic, Mounds View, MN, (3)American Heart Association, Dallas, TX, (4)Food and Drug Adminstration, (5)US Food and Drug Administration, Silver Spring, MD
See more of: SCAI SHOCK